Free Trial
OTCMKTS:IPHYF

Innate Pharma (IPHYF) Stock Price, News & Analysis

Innate Pharma logo
$1.31 0.00 (0.00%)
As of 07/11/2025

About Innate Pharma Stock (OTCMKTS:IPHYF)

Key Stats

Today's Range
$1.31
$1.31
50-Day Range
$1.31
$1.95
52-Week Range
$1.31
$1.95
Volume
N/A
Average Volume
38 shs
Market Capitalization
$109.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Innate Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

IPHYF MarketRank™: 

Innate Pharma scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Innate Pharma.

  • Percentage of Shares Shorted

    0.00% of the float of Innate Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Innate Pharma has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Innate Pharma has recently decreased by 91.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Innate Pharma does not currently pay a dividend.

  • Dividend Growth

    Innate Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of Innate Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Innate Pharma has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Innate Pharma has recently decreased by 91.67%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Innate Pharma this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Innate Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.89% of the stock of Innate Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Innate Pharma's insider trading history.
Receive IPHYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.

IPHYF Stock News Headlines

Innate Pharma S.A. (IPHYF) - Yahoo Finance
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Innate Pharma announces EUR 15M capital increase from Sanofi
See More Headlines

IPHYF Stock Analysis - Frequently Asked Questions

Innate Pharma's stock was trading at $2.90 at the beginning of 2025. Since then, IPHYF stock has decreased by 54.8% and is now trading at $1.31.

Shares of IPHYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/13/2025
Next Earnings (Estimated)
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:IPHYF
Previous Symbol
NASDAQ:IPHYF
CIK
1598599
Employees
179
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.60
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$21.77 million
Price / Sales
5.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
11.91

Miscellaneous

Outstanding Shares
83,830,000
Free Float
57,097,000
Market Cap
$109.82 million
Optionable
Not Optionable
Beta
0.50
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:IPHYF) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners